Miranda Athanasiou-Metaxa
Aristotle University of Thessaloniki
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Miranda Athanasiou-Metaxa.
Acta Haematologica | 2007
Nikolaos Gompakis; Marina Economou; Chaido Tsantali; Vassilios Kouloulias; Maria Keramida; Miranda Athanasiou-Metaxa
Backround: Despite encouraging reports concerning the declining prevalence of iron deficiency, this easily preventable disorder is still an existing problem in presumably developed regions. Objective: To evaluate the prevalence of iron deficiency and relevant anemia in children residing in Northern Greece and to study possible associations. Design: 3,100 children aged 8 months to 15 years were evaluated. Socioeconomic status was determined based on the parents’ profession and place of residence. Nutrition habits were also evaluated. Results: The incidence of iron deficiency was found to be 14% and that of iron deficiency anemia was 2.9%, with a higher prevalence in children younger than 2 years of age. The place of residence was the most significant factor in relation to the development of iron depletion in the children studied. Additional independent factors were revealed to be breast-feeding, meat-containing meal consumption and the consumption of non-home-cooked meals. Conclusion: Iron deficiency remains prevalent in Northern Greece, mainly affecting the vulnerable toddler group. Nutritional iron deficiency is still a severe public health problem even in what are considered to be developed regions. An improvement of dietary habits and an upgrading of semiurban areas should contribute substantially to decreasing the prevalence of iron depletion in Greek children.
Journal of Pediatric Hematology Oncology | 2011
Andromachi Papagianni; Marina Economou; Athanasios Tragiannidis; Eliza Karatza; Nikolaos Gombakis; Fani Athanassiadou-Piperopoulou; Miranda Athanasiou-Metaxa
Background We conducted a study to evaluate the efficacy of intravenous (IV) anti-D against IV immunoglobulin (IVIG) in newly diagnosed immune thrombocytopenia (ITP) in children and to identify the clinical characteristics of the children most likely to benefit from one or the other treatment. Procedure Children (6 mo to 14 y) with newly diagnosed ITP and a platelet count <20,000/&mgr;L were treated either with a single bolus dose of 50 &mgr;g/kg IV anti-D or with 0.8 to 1 g/kg IVIG in a randomized manner. Results Twenty-five patients, mean age of 6.8 years, were treated either with IV anti-D (n=10) or with IVIG (n=15). Both drugs were equally efficient in raising the platelet count above 20,000/&mgr;L at 24 hours posttreatment. Children who presented with bleeding stage 1 or 2 (no mucosal bleeding) responded better to IVIG treatment, in terms of an increase in platelet count at 24 hours posttreatment (P=0.04). Hemoglobin drop was greater in the anti-D group (P=0.002). Conclusions A single bolus dose of 50 &mgr;g/kg of IV anti-D is a safe and effective first-line treatment in newly diagnosed ITP in childhood and mucosal bleeding is a poor prognostic factor for treatment with IVIG.
European Journal of Pediatrics | 2010
Efthimia Vargiami; Evangelia Farmaki; D. Tasiopoulou; Dimitrios I. Zafeiriou; M. Badouraki; A. Anastasiou; Christos D. Karkos; Nikos Gombakis; Miranda Athanasiou-Metaxa
Lemierre syndrome, also known as postanginal sepsis, is a severe complication of an acute oropharyngeal infection that results in septic thrombophlebitis of the ipsilateral internal jugular vein with subsequent septicemia, often complicated by metastatic infections (Syed et al., Laryngoscope 117:1605–1610, 2007). We present the case of a previously healthy 12-year-old boy with Lemierre syndrome, caused by streptococci (Abiotrophia defectiva), complicating a subcutaneous neck abscess. The patient had metastatic sequelae, was treated with antibiotics (clindamycin and vancomycin) and low molecular weight heparin, and had an uneventful outcome.
European Journal of Pediatrics | 2001
Afroditi Koussi; Marina Economou; Miranda Athanasiou-Metaxa
Blood Cells Molecules and Diseases | 2004
Alexandra Stamoulakatou; Miranda Athanasiou-Metaxa; Joanne Traeger-Synodinos; Christina Lazaropoulou; Kees L. Harteveld; Evangelos Premetis; Haido Tsantali; Amine Zorai; Piero C. Giordano; Ioannis Papassotiriou; Emmanuel Kanavakis
Pediatric Neurology | 2008
Euthymia Vargiami; Dimitrios I. Zafeiriou; Nikos Gombakis; Fenella J. Kirkham; Miranda Athanasiou-Metaxa
Journal of Pediatric Hematology Oncology | 2002
Miranda Athanasiou-Metaxa; Marina Economou; Polixeni Pratsidou; Chaido Tsantali
Blood | 2008
Vasilios Perifanis; Efthimia Vlachaki; Emmanouil Sinakos; Raptopoulou-Gigi M; Miranda Athanasiou-Metaxa
Blood | 2011
Vassilis Ladis; Marouso Drossou; Dimitria Vini; Ersi Voskaridou; Miranda Athanasiou-Metaxa; Marina Oikonomou; Efthimia Vlachaki; Anna Tigka; Christos Tzavelas; Theodora Liakopoulou; Eleni Vrettou; Ioannis Adamopoulos; Antonis Kattamis
Blood | 2009
John B. Porter; Miranda Athanasiou-Metaxa; Donald K. Bowden; Jacques Troncy; Dany Habr; Gabor Domokos; Bernard Roubert; Diana Rofail; Adam Gater; Jean-Francois Baladi; M. Domenica Cappellini